Detected ·
Hexagon Bio
$62MSeries C
Menlo Park oncology biotech Hexagon Bio closed a $62M Series C led by The Column Group, bringing total funding to over $240M.
- Website
- —
- —
- Amount
- $62 000 000 USD
- Stage
- Series C
- Event
- Funding round
- Detected
- 2026-10-30 00:10:30 UTC
- Signal ID
- 20bb3a04-20ad-4a60-951d-ccd83b7a5d2c
As the API returns it
{
"id": "20bb3a04-20ad-4a60-951d-ccd83b7a5d2c",
"created_at": "2026-10-30T00:10:30.631122Z",
"company_name": "Hexagon Bio",
"company_website_url": null,
"company_linkedin_url": null,
"event_type": "funding",
"funding_amount": 62000000,
"funding_currency": "USD",
"funding_stage": "series_c",
"message": "*Menlo Park oncology biotech Hexagon Bio closed a $62M Series C led by The Column Group, bringing total funding to over $240M.*"
}